According to "Notice of the Zhejiang Provincial Department of Economy and Information Technology on Organizing the Cultivation and Promotion of Key Biomedical Enterprises in 2023" (Zhejiang EIT [2024] No. 21), an for organized the application for key biomedical enterprises and selection work, RoboCT was successfully shortlisted for the high-growth enterprises in biomedical of Zhejiang Province.

RoboCT's being selected into the list fully reflects its innovation capabilities and market competitiveness in the field of medical and healthcare. Over the years, RoboCT has focused on the industry's R&D, and continuously improved technology and service quality, relying on advanced technology platforms and professional R&D teams, RoboCT strives to build a first-class enterprise with international influence.

In the future, RoboCT will continue to deepen its connections with multiple partners within the industry, form synergy through government-enterprise linkage, and actively participate in various exhibitions, technical seminars and other publicity and promotion, jointly explore new paths for industry innovation and cross-border integration to achieve win-win development.